SHOP BEST SELLERS
Shop our best selling products
Type: Performance Supplements
Protein Powder
Type: Performance Supplements
Electrolytes - Stick Packs
Type: Performance Supplements
Electrolytes
Type: Performance Supplements
Creatine Monohydrate
Type: Core Supplements
Source Magnesium
Type: Core Supplements
Vitamin D3 & K2
Type: Body Essentials
Raw Elements Shampoo
Type: Body Essentials
Raw Elements Conditioner
Type: Body Essentials
Raw Elements Tallow Soap (Lemongrass)
Type: Performance Supplements
Raw Honey
Type: Body Essentials
Raw Tallow Sun Balm
Pure ingredients
Raw ingredients. Ancient wisdom. Modern results. Every product contains only what nature intended:
- Grass-fed tallow rich in bioavailable nutrients
- Raw honey and adaptogenic herbs in their purest form
- Regeneratively sourced proteins, never denatured
- Zero synthetic additives or lab-made fillers
Small-batch wellness our ancestors would recognize. Because when you honor nature's integrity, your body knows the difference.
Purely Natural, Perfectly You
Let customers speak for us
Absolutely love these electrolytes. The only CLEAN brand I can find that doesn’t have fake sugars and additives. I love to mix mine with ice and coconut water 🤩
Smells great!!
Great oroduct
Great product
Sleeping much better
Works great and leaves my hair very soft.
Solid taste.
Wish I had more money to try other products.
Great
It’s perfect and I love it 😍
I don't know why but I use this everyday.
Works great!
Great customer service
The taste and quality of this honey is amazing, bought 2 and definitely will buy again.
Love it!
The best! Amazing! Love it! And my kids also love it :)
Why Purishh?
Pure Ingredients
Handpicked and ethically sourced from trusted, natural farms.
Effective Results
Each product is designed to protect, nourish, and enhance your skin’s natural balance.
Holistic Wellness
Embrace a balanced lifestyle with supplements and creams that work in harmony with your body.
Frequently Asked Question
What makes Purishh products different from conventional supplements or skincare?
What makes Purishh products different from conventional supplements or skincare?
Purishh’s mission is to return to the raw, unprocessed power of nature. Every product is formulated with 100 % natural ingredients and no synthetic preservatives, fillers, or dyes. For example, the Raw Honey Butter contains whipped Wagyu beef tallow, cold‑pressed olive and coconut oils, mango butter, raw honey and beeswax – it moisturizes deeply and can even replace conventional lotion. The Raw Tallow Sunbalm uses grass‑fed tallow, non‑nano zinc oxide and organic oils to provide mineral sun protection while nourishing the skin. Purishh’s Protein Powder combines grass‑fed whey and hydrolyzed collagen with organic superfoods to deliver 26 g of easily digestible protein with zero added sugar. Across their range, Purishh keeps ingredient lists short and transparent, using only what is necessary to support health and well‑being.
Are Purishh’s ingredients ethically and sustainably sourced?
Are Purishh’s ingredients ethically and sustainably sourced?
Yes. The founders emphasize sustainable sourcing and ethical treatment of animals and land. Tallow for the skincare range is hand‑sourced from 100 % grass‑fed, Wagyu, halal cattle in New Zealand, ensuring humane slaughter and optimal nutrient quality. Olive and coconut oils are single‑origin, cold‑pressed. The whey in Purishh protein powder comes from grass‑fed cows raised without hormones or antibiotics, and the collagen is hydrolyzed for better absorption. These practices mean customers receive products that are both pure and sustainable.
Why does Purishh use beef tallow in its skincare products?
Why does Purishh use beef tallow in its skincare products?
Grass‑fed beef tallow is biocompatible with human skin; its fatty‑acid profile closely resembles natural sebum, so it’s absorbed efficiently. Properly rendered tallow is a vitamin powerhouse, naturally supplying vitamins A, D, E, and K that support cell turnover, immune function, and antioxidant protection. Tallow also contains oleic, stearic and palmitic acids that strengthen the skin’s barrier, calm inflammation and maintain moisture. Grass‑fed tallow offers a high concentration of conjugated linoleic acid (CLA), an anti‑inflammatory fatty acid. These nutrients collectively help Purishh’s Raw Honey Butter and Raw Tallow Sunbalm to moisturize, nourish and protect the skin without clogging pores or causing irritation.
How is Purishh protein powder different, and why is it easy to digest?
How is Purishh protein powder different, and why is it easy to digest?
Many conventional protein powders use cheap sources and add artificial thickeners or sweeteners that cause bloating and digestive discomfort. Purishh starts with grass‑fed whey processed via cold‑filtration, which preserves natural enzymes and bioactive peptides that aid digestion. It also adds hydrolyzed bovine collagen to support joints, skin and gut health. The powder uses organic monk fruit for sweetness and contains no carrageenan, gums, sucralose or artificial preservatives, so it mixes smoothly and is gentle on the stomach. Each serving provides 26 g of complete protein with only 1 g of fat and zero sugar, making it suitable for keto, gluten‑free and non‑GMO diets.
What are Purishh Electrolytes, and how do they support hydration?
What are Purishh Electrolytes, and how do they support hydration?
Purishh’s Electrolytes formula offers clean hydration without the artificial colors and preservatives found in many sports drinks. Each serving includes over 800 mg of unrefined Himalayan salt, providing sodium and trace minerals, plus magnesium malate and potassium chloride. Organic fruit powders (raspberry or lemon‑lime) and monk fruit sweetener give a natural flavor without sugar. The formula helps replenish electrolytes lost through exercise, supports muscle function, and is keto‑friendly.
What is Raw Shilajit, and how should it be used?
What is Raw Shilajit, and how should it be used?
Raw Shilajit is a resin harvested from high‑altitude Himalayan rocks. It forms from decomposed plant material and is rich in minerals and fulvic acid. Traditionally used as an adaptogen, Shilajit helps boost energy, improve stamina and support overall health. Purishh provides 100 % pure Himalayan shilajit. Users typically dissolve a pea‑sized amount in warm water, tea or milk. Due to its potent minerals, start with a small dose and consult a healthcare professional if you have existing medical conditions.
What is the Ishh Leaky Gut Protocol?
What is the Ishh Leaky Gut Protocol?
The Ishh Leaky Gut Protocol is a step‑by‑step program designed to help restore gut health naturally. It includes dietary recommendations, lifestyle tips and natural supplements to support the intestinal lining. The protocol focuses on removing irritants, replenishing beneficial bacteria and repairing the gut barrier. It is not a medical treatment, so customers with chronic digestive issues should consult a healthcare professional before starting.
How should I store Purishh products?
How should I store Purishh products?
Store supplements and protein powders in a cool, dry place away from direct sunlight. Skincare products like Raw Honey Butter and Raw Tallow Sunbalm are natural and free from artificial stabilizers; keeping them at room temperature helps maintain texture. If you live in a hot climate, refrigerating tallow‑based balms can prevent melting. Always use clean hands or a spatula to avoid introducing bacteria.
When will my order ship, and how long will delivery take?
When will my order ship, and how long will delivery take?
Purishh asks customers to allow 2–3 business days for processing and production before an order ships. Once dispatched, average transit times are 7–10 business days; however, natural disasters, holidays and weather can cause delays. Free standard shipping is offered on orders over US$150 (or equivalent), and shipping costs for smaller orders are calculated at checkout. Purishh cannot guarantee exact delivery dates because delivery is ultimately the responsibility of the shipping carrier.
Can I subscribe and save on regular purchases?
Can I subscribe and save on regular purchases?
Yes. Purishh offers a subscription program for products like protein powder. Subscribing gives 10 % off the regular price, and you can choose delivery intervals (e.g., monthly). Subscriptions auto‑renew, but you may skip or cancel at any time through your account.
Are Purishh products allergen‑free or suitable for special diets?
Are Purishh products allergen‑free or suitable for special diets?
Purishh formulates products without common synthetic additives, but some items may contain potential allergens. The protein powder contains whey (a dairy product) and collagen derived from bovine sources; it is unsuitable for vegans or those with dairy allergies. The Electrolytes formula is gluten‑free, sugar‑free and keto‑friendly. Always review ingredient lists carefully and consult your healthcare provider if you have specific allergies or dietary restrictions.
Where are Purishh products made?
Where are Purishh products made?
Purishh sources ingredients globally, such as New Zealand Wagyu tallow and Himalayan shilajit, but manufactures products in small batches under rigorous quality control. By keeping production small and hands‑on, Purishh can maintain freshness and ensure every batch meets the highest standards.
Pür Insights
Vitamin D3 and K2 for Bone Health: What a 3-Year Study Found
A specific study gets cited constantly in vitamin K2 marketing: a three-year trial finding that a small daily dose of MK-7 protected postmenopausal women's bones. It's a real, well-designed, peer-reviewed trial, and it deserves a genuinely careful look rather than a one-line mention. It also exists inside a body of evidence that's considerably more mixed than most content citing it lets on, including other rigorous, similarly long trials that found the opposite result. This post goes deep into exactly what the headline study found, what it didn't find, and how it fits into the broader, genuinely unsettled research picture on vitamin K2 and bone health. That fuller picture is more useful, and more honest, than a single dramatic finding presented as if the question were closed. The trial itself, in detail The study is Knapen, Drummen, Smit, Vermeer, and Theuwissen, "Three-year low-dose menaquinone-7 supplementation helps decrease bone loss in healthy postmenopausal women," published in Osteoporosis International in 2013. The research came out of Cees Vermeer's group at Maastricht University, a lab with a long-standing research program specifically on vitamin K and bone health, and this trial was designed as a direct follow-up to the same group's earlier work showing that higher-dose vitamin K1 and short-chain K2 (MK-4) supplementation improved postmenopausal bone health. The 2013 trial specifically tested whether a much lower dose of the long-chain form, MK-7, chosen for its longer half-life and greater potency at lower doses, could achieve similar results. The trial enrolled 244 healthy postmenopausal women between the ages of 55 and 65, randomized in a double-blind, placebo-controlled design to receive either 180 micrograms of MK-7 daily or a placebo, for three years. Bone outcomes were tracked at multiple sites and multiple timepoints across that period. Here's where precision matters, because the actual findings are more specific than "vitamin K2 improved bone density." MK-7 supplementation significantly decreased the age-related decline in bone mineral density and bone mineral content at the lumbar spine and at the femoral neck. It did not produce a significant difference at the total hip, a separate measurement site that showed no meaningful group difference. For bone strength specifically, rather than density alone, the trial measured vertebral height loss at the mid-site of the lower thoracic vertebrae, a recognized marker of vertebral compression and structural weakening, and found that MK-7 significantly reduced this loss compared to placebo. One more detail from the study is worth knowing because it directly explains why the trial ran three years rather than something shorter: during the first year, the rate of bone loss was similar between the MK-7 and placebo groups. The measurable difference between groups only emerged after the second and third years. This is a meaningful methodological point. A shorter trial, the kind more commonly run in supplement research for cost and feasibility reasons, would very plausibly have found nothing, not because the effect isn't real, but because it may take longer than a year to become detectable against the underlying rate of postmenopausal bone loss. The mechanism, briefly The biological rationale connecting vitamin K2 to bone health runs through a specific protein called osteocalcin, produced by bone-building cells and requiring a vitamin K-dependent chemical modification, carboxylation, to properly bind calcium and function in bone mineralization. Without adequate vitamin K, osteocalcin remains in an undercarboxylated state and works less effectively. K2 specifically, rather than K1, is the form most directly involved in activating this pathway outside the liver, in tissues like bone. This mechanism is genuinely well established at the biochemical level. What's less settled is whether reliably improving this biomarker, undercarboxylated osteocalcin levels, reliably translates into measurably better bone density or strength outcomes in every population and every trial design. That gap between "the biomarker improves" and "the clinical bone outcome improves" is exactly where the research picture gets more complicated. What other rigorous trials found This is the part that a lot of content built around the Knapen study leaves out entirely, and it's worth including in full, because it changes how confidently the finding should be presented. A 2010 randomized, double-blind, placebo-controlled trial by Emaus and colleagues, published in the same journal, Osteoporosis International, enrolled 334 healthy Norwegian women between 50 and 60 years old, one to five years past menopause. Participants received either 360 micrograms of MK-7, in Natto-derived capsule form, or a matching placebo, for one year. The trial found that vitamin K2 supplementation had no effect on bone loss rates in this population over that period. A more recent and, in some ways, more directly comparable trial is worth weighing carefully against the Knapen findings. Published in Osteoporosis International in 2020, this randomized, placebo-controlled, double-blind trial specifically enrolled 142 postmenopausal women who already had osteopenia, reduced bone density short of full osteoporosis, arguably a more clinically relevant population than generally healthy postmenopausal women, since these are people who might actually be advised to consider a bone-supportive intervention. Participants received 375 micrograms of MK-7 daily, a notably higher dose than the 180 micrograms used in the Knapen trial, for three years, the same duration. The result: bone mineral density decreased at all measured sites, with no significant difference between the MK-7 and placebo groups. Bone turnover markers and bone microarchitecture also showed no meaningful difference between groups. A separate trial by Binkley and colleagues, published in the Journal of Bone and Mineral Research in 2009, examined vitamin K treatment in healthy postmenopausal North American women and found that treatment successfully reduced undercarboxylated osteocalcin, confirming the biomarker mechanism worked as expected, but did not alter bone turnover, density, or geometry. This is a particularly clean illustration of the gap described above: the biochemical pathway activated exactly as predicted, and it still didn't produce a detectable difference in actual bone outcomes. Put plainly: at least three separate, well-designed, placebo-controlled randomized trials, including one of identical three-year duration in a more clinically relevant osteopenic population using a higher MK-7 dose than the Knapen trial, found no significant bone benefit from vitamin K2 supplementation. This doesn't erase the Knapen findings. It means the honest state of the evidence is genuinely mixed, not a settled, one-directional result. Why these trials might disagree Reasonable, evidence-grounded possibilities exist for why studies using similar interventions reached different conclusions, and it's worth naming them rather than treating the disagreement as unexplainable. Population differences may matter. The 2020 osteopenia trial studied women who already had reduced bone density, and it's biologically plausible that bone tissue already undergoing accelerated loss responds differently to a K2 intervention than the more generally healthy bone density range studied in the original Knapen trial, though this cuts both ways and doesn't obviously predict which direction the effect should go. Duration and timing may be part of the answer, and this is where the Knapen trial's own internal data is most instructive. Its own results showed no detectable difference in year one, with effects only emerging in years two and three. The Emaus trial ran only one year, precisely the window in which Knapen's own data showed no group difference yet. It's a reasonable, if not proven, hypothesis that some of the disagreement across this research reflects trials that simply didn't run long enough to detect a genuinely slow-developing effect, rather than K2 having no effect at all. Baseline vitamin K status across different study populations, which typically isn't tightly controlled for or reported in detail, could also plausibly influence results, since a population already reasonably K2-replete through diet might show less room for a supplemental benefit than a population with lower baseline status, though this is speculative without directly comparable baseline data across these specific trials. None of these explanations should be read as evidence that the positive Knapen result is definitely the "true" one and the null results are artifacts. It's equally possible that the Knapen result reflects a real, if modest and site-specific, effect that other trials genuinely didn't replicate for reasons not yet fully understood, or that publication and citation patterns have simply amplified one positive trial while contradictory findings received comparatively little attention, a well-documented general pattern across nutrition research. What this means for reading "a study found" claims generally This is a useful case study in a broader habit worth building as a health-conscious reader of research: when a single trial gets cited repeatedly and confidently, particularly in marketing contexts, it's worth checking whether that trial exists in isolation or within a body of research that includes contradicting findings. In this specific case, the Knapen 2013 trial is a real, rigorous, three-year randomized controlled trial that found a statistically significant, site-specific benefit for MK-7 supplementation on postmenopausal bone density and vertebral strength, with an important caveat that the effect wasn't uniform across every measured site and took more than a year to become detectable. It sits alongside at least three other well-designed trials, including one of equal duration in a more clinically relevant population at a higher dose, that found no significant bone benefit. Both facts are true. Presenting only the first is an incomplete picture, however accurate each individual sentence about the Knapen trial might be. The honest bottom line Vitamin K2, and MK-7 specifically, has a real, biochemically well-established mechanism connecting it to bone metabolism through osteocalcin carboxylation, and that mechanism is not in serious scientific dispute. Whether supplementing with it reliably improves measurable bone density or strength outcomes in postmenopausal women is a genuinely open question, supported by at least one well-designed three-year trial showing a real, if site-specific, benefit, and contradicted by other equally rigorous trials, including one of the same duration in a population arguably more relevant to real-world supplementation decisions. If you're taking vitamin D3 and K2 together, the case for D3's role in calcium absorption remains well supported independent of this specific question. The case for K2 meaningfully improving bone density outcomes, based on the totality of the randomized trial evidence rather than any single study, is best described as promising and mechanistically sound, not settled. That's a more complicated answer than "a 3-year study proved it works," and it's the answer the actual evidence supports.
Learn more
Do You Need Electrolytes Every Day, or Only When You Sweat?
The honest answer isn't a yes or no. It's a function of a few specific, measurable variables, how much you're actually sweating, how salty that sweat is, how long and how intensely you're exercising, and what your baseline diet already provides, that together determine whether daily supplementation makes physiological sense for you specifically. Marketing in this category tends to flatten all of that into a blanket recommendation. The actual sports science literature is considerably more precise, and considerably more interesting. This post walks through what the research establishes about when electrolyte needs actually increase, how much individual variation genuinely exists, and a safety consideration that gets left out of almost every electrolyte marketing conversation: that more isn't automatically better, and the science behind why is worth understanding. What the governing sports medicine guidance actually says The most authoritative, most frequently cited guidance on this exact question comes from the American College of Sports Medicine's Position Stand on Exercise and Fluid Replacement, first published in 1996 and updated in 2007 by Michael Sawka and colleagues in Medicine & Science in Sports & Exercise. This isn't a supplement company's internal guideline. It's a formal position statement from one of the most established professional bodies in sports medicine, based on a comprehensive review of the available research. The specific, quantified guidance is worth knowing precisely rather than in vague summary. The ACSM recommends adding electrolytes to a fluid replacement strategy specifically for exercise events lasting longer than one hour, noting that for shorter durations, there's little evidence of a meaningful physiological or performance difference between plain water and electrolyte-containing beverages. For longer, sustained efforts, the ACSM's specific sodium recommendation is 500 to 700 milligrams, or roughly 22 to 30 milliequivalents, per liter of fluid consumed, aimed at replacing what's actually being lost through sweat during sustained activity. That one-hour threshold is doing a lot of work in answering the question this post is actually asking. It's not "do you sweat," since almost any physical activity produces some sweat. It's whether the activity is sustained and intense enough, for a long enough duration, that meaningful electrolyte losses actually accumulate to a level worth actively replacing. A twenty-minute walk and a two-hour training session in the heat are not the same question, even though both technically involve sweating. The individual variation is larger than most people assume Here's where the science gets genuinely more specific than "sweat means you need electrolytes." How much sodium you actually lose depends on two separate variables that both vary enormously between individuals: how much you sweat, and how much sodium is in that sweat. A 2016 study published in the Journal of the International Society of Sports Nutrition, led by Beatriz Lara and colleagues, measured sweat electrolyte concentration directly in 157 experienced marathon runners during an actual race, using sweat patches and photoelectric flame photometry to analyze samples. The study documented substantial interindividual variability in sweat sodium concentration among the runners, reinforcing something separately confirmed by a large normative dataset from researcher Lindsay Baker and colleagues, who analyzed sweat sodium concentration across more than 1,300 athletes and published the results in the European Journal of Applied Physiology. Across this broader body of research, sweat sodium concentration commonly ranges from roughly 200 milligrams per liter at the low end to over 2,000 milligrams per liter at the high end, an approximately tenfold difference between the least and most "salty" sweaters, with genetics as the primary driver of where any individual falls on that range. Sweat rate itself varies substantially too, commonly cited in the range of roughly 0.5 to 2 liters per hour depending on exercise intensity, ambient heat and humidity, and individual physiology, with some individuals in extreme heat or high-intensity conditions producing considerably more. Because total sodium loss is the product of both sweat rate and sweat sodium concentration, two people doing the identical workout, in the identical conditions, can have genuinely different electrolyte replacement needs, sometimes by a factor of several times over. A generic sports drink formulated for an average sweater may replace only a fraction of what a genuinely salty, heavy sweater is actually losing, while providing more sodium than a low sweat-rate, low sodium-concentration individual needs at all. This is the specific, research-grounded reason a blanket "everyone should drink electrolytes daily" recommendation doesn't hold up to scrutiny. The people for whom daily supplementation makes clear physiological sense, heavy and salty sweaters engaged in sustained, intense activity regularly, are a real and identifiable group. They are not the same as "anyone who exercises," and they're certainly not the same as "everyone." Why more electrolytes isn't automatically safer This is the part of the conversation that gets left out of almost all electrolyte marketing, and it's worth taking seriously because it's a genuine, documented safety consideration rather than a minor technicality. Exercise-associated hyponatremia, an abnormally low blood sodium concentration that can occur during or after prolonged exercise, is a real and studied medical phenomenon, first documented in ultramarathon and marathon athletes decades ago and since studied extensively enough to have its own dedicated body of clinical literature on pathophysiology and treatment. The ACSM's own position stand references early documented cases of what was then called water intoxication in athletes. Here's the mechanism, and it's the part that surprises people: exercise-associated hyponatremia is fundamentally caused by overdrinking, consuming more total fluid volume than the body is losing through sweat, which dilutes blood sodium concentration regardless of what's dissolved in that fluid. It is not simply a matter of insufficient electrolyte intake. The distinction matters enormously for how you think about daily electrolyte use, because it means the fix isn't just "add more sodium to your water." A meaningful detail from the research literature on this topic: most commercial sports drinks are actually hypotonic relative to blood serum, meaning they contain considerably less sodium per liter, roughly 10 to 38 millimoles per liter in typical sports drinks, compared to blood serum's sodium concentration of roughly 140 millimoles per liter. Drinking large volumes of a hypotonic beverage, even one marketed specifically for hydration and electrolyte replacement, can still contribute to the same dilution problem if the total fluid volume significantly exceeds what's actually being lost. This is directly reflected in the current evidence base: a body of research specifically examining whether sodium supplementation during exercise prevents exercise-associated hyponatremia has found insufficient evidence that it reliably does, since the volume of fluid consumed, not just its sodium content, is the more direct driver of the dilution risk. This is a genuinely important, somewhat counterintuitive nuance. Reaching for an electrolyte drink specifically because you're worried about hyponatremia isn't a complete solution if you're also drinking considerably more total fluid than your actual sweat losses warrant. None of this means electrolyte beverages are dangerous or that the concern applies to typical daily use. It means the honest, research-supported picture is more nuanced than "electrolytes prevent dehydration problems and more is safer." Matching fluid intake to actual losses, rather than maximizing either water or electrolyte intake independently, is what the evidence actually supports. The non-exercise context: a genuinely different question Everything above concerns exercise-driven electrolyte needs specifically. There's a separate, distinct context where daily electrolyte attention may be warranted regardless of how much you're sweating, and it's worth being precise that this is a different mechanism entirely. Reducing dietary carbohydrate intake significantly, through a ketogenic, low-carb, or carnivore approach, lowers circulating insulin levels, and insulin has a direct effect on how much sodium your kidneys retain versus excrete. Lower insulin signals increased sodium excretion, independent of activity level or sweating. This is a well-documented physiological mechanism behind what's commonly called the early adaptation symptoms of carbohydrate restriction, and it's a genuinely separate reason someone might reasonably consider more consistent sodium intake, tied to a dietary pattern rather than to exercise or heat exposure at all. Someone in this specific dietary context, even living a largely sedentary life, may have a real, physiologically grounded reason for more consistent electrolyte attention than someone eating a typical mixed diet and not exercising intensely. This is worth separating clearly from the exercise-based conversation above, because conflating "I sweat a lot" with "I'm on a low-carb diet" as if they're the same justification for daily electrolyte use would be inaccurate. They're two different mechanisms that happen to point toward a similar practical behavior for the specific people they apply to. A practical framework, based on what actually determines the answer Given the research above, here's how the actual determining factors sort people into different answers, rather than one universal rule. If your typical activity involves sustained effort beyond roughly an hour, particularly in heat, and especially if you notice visible salt residue on skin or clothing after exercising, a common informal indicator of higher sweat sodium concentration, the case for regular, exercise-day electrolyte replacement is well supported by the ACSM guidance and the individual variability research above. This describes a genuine and identifiable population, not an exaggeration. If your activity is generally shorter than an hour, moderate in intensity, or not conducted in significant heat, the ACSM's own position is that plain water is unlikely to be meaningfully different from an electrolyte beverage for that specific session, based on the available evidence. If you're following a significantly carbohydrate-restricted diet, the case for more consistent daily sodium attention exists independent of your exercise pattern, for the insulin-related reasons described above, though this is a different justification than an exercise-based one and worth understanding as such. And regardless of which category you fall into, the overhydration and dilution research is a genuine reason to think about matching total fluid intake to actual losses, rather than assuming more fluid, electrolyte-containing or not, is inherently the safer choice. The ACSM's own practical suggestion, weighing yourself before and after a typical training session to estimate your actual fluid loss, remains one of the more useful, low-effort ways to move from a generic assumption to an answer based on your own actual numbers. The honest summary: "every day" is the right answer for a specific, identifiable subset of people, defined by measurable factors like sweat rate, sweat sodium concentration, activity duration and intensity, and dietary context. "Only when you sweat significantly, for a sustained period" is the more accurate default for most people doing moderate, shorter-duration activity. And "constantly, regardless of actual fluid losses" isn't well supported by the research at all, which is worth knowing given how often that's the implicit message in how this category gets marketed.
Learn more
How Much Magnesium Is Too Much?
The number most commonly cited is 350 milligrams a day, and it's worth knowing upfront that this figure gets misunderstood in a specific, important way almost every time it's repeated. It isn't a toxicity threshold. It's the point at which a specific, mild, and reversible side effect, diarrhea, starts becoming more likely in clinical trials. Actual magnesium toxicity, the kind that involves real medical risk, is a different and much rarer phenomenon with a very specific risk profile that has almost nothing to do with a healthy adult taking a standard supplement. This post separates those two things clearly, with the actual research and clinical data behind each, because conflating "you might get loose stools" with "you might be poisoned" is where a lot of magnesium safety content goes wrong in both directions, either dismissing a real number too casually or treating a mild GI threshold like a medical emergency line. Where the 350 milligram number actually comes from The Tolerable Upper Intake Level for supplemental magnesium in adults, 350 milligrams per day, was established by the US Institute of Medicine's Dietary Reference Intakes committee in 1997. According to the NIH Office of Dietary Supplements, which maintains the current official guidance, this figure applies specifically to magnesium from supplements and medications, not from food, and diarrhea was explicitly the limiting factor used to set it. This is a genuinely important distinction: the UL wasn't derived from evidence of organ damage or systemic toxicity at that dose. It was derived from the dose at which a meaningful share of people in clinical studies started experiencing GI upset. This matters because it changes what "exceeding the UL" actually means for most people. It doesn't mean you've entered dangerous territory. It means you've entered the range where loose stools become statistically more likely, a real but minor and fully reversible effect that resolves once intake decreases. It's also worth knowing that this exact number is a subject of legitimate, ongoing scientific debate, not settled beyond question. A 2023 perspective paper by Rebecca Costello and colleagues at the Center for Magnesium Education and Research, published in the journal Advances in Nutrition, reviewed intervention studies published since the original 1997 UL was set and argued the threshold may be overly conservative. Their review found that one meta-analysis showed only minor GI differences between a placebo group and a group taking 520 milligrams of magnesium daily, and that a search of the FDA's adverse event reporting system, limited specifically to single-ingredient magnesium products, found only 40 attributable cases of GI adverse events across the available data, with only about a third of those actually reporting diarrhea. The authors argue this supports raising the UL rather than keeping it fixed at a level set nearly three decades ago on more limited data. We're not citing this to say the official 350 milligram guidance is wrong, since it remains the current standard recommendation from NIH and is a reasonable, conservative reference point. We're citing it because it's useful to understand that even nutrition scientists actively studying this question see the current number as a debatable, evidence-based estimate rather than a fixed biological wall, which is a more honest picture than either "350 mg is a hard safety limit" or "the number doesn't matter at all." Food magnesium and supplemental magnesium are genuinely different situations One thing the research is consistent and clear about: the UL doesn't apply to magnesium from food, and there's a real physiological reason why. According to the NIH fact sheet, the risk of getting too much magnesium from food alone is low among healthy people, because the kidneys are highly effective at clearing excess magnesium absorbed through normal digestion. You'd have a very hard time eating your way to a magnesium problem through spinach, almonds, and black beans, which is part of why toxicity from diet alone is essentially unreported in the medical literature. Supplements and magnesium-containing medications are a different situation, not because the magnesium itself behaves differently, but because they deliver a concentrated dose in a form your gut absorbs and your kidneys have to process all at once, rather than the slower, more gradual absorption that comes with eating magnesium-containing foods throughout a meal. What actual magnesium toxicity looks like, and why it's rare True hypermagnesemia, an elevated blood magnesium level with real clinical significance, is defined by the Merck Manual as a serum magnesium concentration above 2.6 milligrams per deciliter. The Merck Manual states plainly that kidney failure is the major cause. This single fact does more to explain the real safety picture than almost anything else in this topic. Your kidneys are responsible for the vast majority of magnesium regulation in your body, reabsorbing or excreting it as needed to keep blood levels in a narrow, stable range. In someone with healthy kidney function, this system is remarkably effective, which is a major reason true magnesium toxicity in the general population is rare even though magnesium supplement use is widespread. When kidney function is significantly impaired, that regulatory system breaks down, and magnesium can accumulate to genuinely dangerous levels from doses that would be completely unremarkable for someone with normal kidney function. This isn't a theoretical concern. The medical literature contains a consistent, repeated pattern of case reports, and it's worth understanding what they actually show rather than treating them as generic scare stories. A 2014 case report in Case Reports in Nephrology described a 70-year-old man with renal failure who developed severe, symptomatic hypermagnesemia after using over-the-counter magnesium-containing laxatives, ultimately requiring treatment with hemodialysis. A case series published in 2019 described four elderly patients with chronic kidney disease who developed severe hypermagnesemia from magnesium oxide, a common over-the-counter laxative ingredient, at doses their bodies simply couldn't clear given their reduced kidney function. A more recent case from a peritoneal dialysis patient found a serum magnesium level of 8.4 milligrams per deciliter, more than three times the toxicity threshold, again traced back to magnesium oxide taken as a laxative in someone whose kidney function couldn't keep pace with the dose. Notice the pattern across essentially every serious case report in this area: magnesium-containing laxatives or antacids, not typical dietary supplements, combined with meaningfully reduced kidney function, frequently in elderly patients. This is a genuinely different risk profile than a healthy adult taking a standard magnesium glycinate or citrate supplement at a normal dose. It's worth being honest that kidney impairment isn't the only contributing factor ever documented. A 2024 case report described near-fatal hypermagnesemia in a patient with normal kidney function, tied instead to reduced gastrointestinal motility from an underlying condition, which prevented the usual safety mechanism, diarrhea flushing out excess magnesium before it could be absorbed in dangerous amounts, from doing its job. This is a rare and specific scenario, but it's an honest reminder that kidney function is the dominant risk factor, not the only one, and that anything significantly slowing gut transit changes the safety calculation. The elemental magnesium distinction that changes the math A detail worth understanding clearly, because it affects how close any given product actually brings you to the UL: the 350 milligram figure refers to elemental magnesium, the actual magnesium content, not the total weight of whatever magnesium compound is on the label. Different magnesium compounds contain very different percentages of elemental magnesium by weight, because the rest of the compound's weight comes from whatever the magnesium is bound to. Magnesium oxide carries a relatively high percentage of elemental magnesium per gram compared to many other forms, which sounds like an advantage until you factor in that it's also poorly absorbed and among the forms most associated with GI symptoms, meaning a large share of an oxide dose sits in the gut drawing in water rather than being absorbed into circulation, which is exactly the mechanism behind its laxative effect and its outsized role in the hypermagnesemia case reports above. Forms like glycinate carry a lower percentage of elemental magnesium per gram, since a meaningful share of the compound's weight comes from the glycine molecules it's bound to, which is part of why gram-for-gram doses of different forms aren't directly comparable, and why two products both listing "500 milligrams of magnesium" on the label can deliver meaningfully different actual amounts depending on which compound that 500 milligrams refers to. The practical takeaway: reading a label as "milligrams of magnesium" without checking whether that's elemental magnesium or total compound weight can lead to a real miscalculation of how close you actually are to any given intake target, in either direction. What actually happens as intake increases, in order It's useful to understand the real progression of effects, since "too much magnesium" isn't a single outcome, it's a spectrum. At the lower end of excess, generally somewhere above the 350 milligram supplemental threshold depending on the form and the individual, the most common effect is loose stools, mild nausea, or abdominal cramping. This is uncomfortable but not dangerous, and it resolves once intake is reduced. This is, by a wide margin, the most likely outcome anyone reading this article who takes too much magnesium will actually experience. At meaningfully higher, sustained doses, particularly in the specific risk contexts described above, kidney impairment, magnesium-containing laxatives or antacids taken repeatedly, reduced gut motility, symptoms can progress toward the territory the NIH fact sheet describes: hypotension, difficulty breathing, irregular heartbeat. This progression requires a combination of a genuinely large intake and an impaired ability to clear it, which is why it shows up in the case report literature almost exclusively in specific vulnerable populations rather than in healthy adults taking standard supplements. At the extreme end, which the case reports above illustrate, severe hypermagnesemia can cause cardiac arrest and has been associated with documented fatalities, though these cases are consistently found in patients with significant kidney impairment who received large, repeated, or intravenous magnesium doses, not in the general population of magnesium supplement users. Practical takeaways For a healthy adult with normal kidney function taking a standard magnesium supplement, meaningful toxicity risk is low, and the primary thing worth paying attention to is GI tolerance, adjusting the dose or the form if loose stools or cramping show up. Gentler, better-absorbed forms tend to produce fewer GI symptoms at a given elemental dose than forms like oxide, which is worth knowing if a particular product isn't agreeing with you. If you have any degree of kidney disease, or you're regularly using magnesium-containing laxatives or antacids in addition to a standard supplement, the calculation changes meaningfully, and this is a genuine conversation worth having with your doctor rather than something to self-manage, given what the case report literature consistently shows about who actually ends up with serious hypermagnesemia. And it's worth remembering that the 350 milligram figure, while a reasonable and official reference point, is a GI-comfort guideline rather than a toxicity line, a genuine distinction the researchers who study this continue to actively discuss. Going modestly over it isn't a safety event. It's a signal, at most, that your gut may start telling you about it before anything more serious ever becomes relevant.
Learn more